The China Mail - US greenlights pig kidney transplant trials

USD -
AED 3.672497
AFN 62.999981
ALL 82.597888
AMD 368.090629
ANG 1.790403
AOA 916.999951
ARS 1477.494302
AUD 1.449359
AWG 1.80125
AZN 1.703214
BAM 1.71493
BBD 2.014108
BDT 123.249054
BGN 1.69088
BHD 0.377034
BIF 2975.014577
BMD 1
BND 1.293507
BOB 6.925154
BRL 5.163806
BSD 1.000039
BTN 94.490039
BWP 13.589892
BYN 2.900133
BYR 19600
BZD 2.011197
CAD 1.42031
CDF 2267.498196
CHF 0.808525
CLF 0.023438
CLP 923.329684
CNY 6.79815
CNH 6.797225
COP 3444.23
CRC 453.586914
CUC 1
CUP 26.5
CVE 96.684671
CZK 21.27015
DJF 178.074144
DKK 6.55298
DOP 59.466972
DZD 133.173774
EGP 49.2502
ERN 15
ETB 161.218522
EUR 0.876703
FJD 2.24625
FKP 0.757857
GBP 0.755845
GEL 2.644968
GGP 0.757857
GHS 11.31015
GIP 0.757857
GMD 73.00006
GNF 8766.638023
GTQ 7.629344
GYD 209.175084
HKD 7.84245
HNL 26.761891
HRK 6.605298
HTG 130.701074
HUF 310.650997
IDR 17852
ILS 2.975675
IMP 0.757857
INR 94.48245
IQD 1309.991977
IRR 1375249.999761
ISK 126.250422
JEP 0.757857
JMD 157.463469
JOD 0.708997
JPY 161.849503
KES 129.479564
KGS 87.450271
KHR 4021.166805
KMF 433.999793
KPW 900.00035
KRW 1543.530303
KWD 0.309701
KYD 0.833333
KZT 485.532407
LAK 22428.570802
LBP 89548.611111
LKR 336.248811
LRD 181.993547
LSL 16.430491
LTL 2.95274
LVL 0.60489
LYD 6.424601
MAD 9.371084
MDL 17.675014
MGA 4255.281837
MKD 54.035217
MMK 2099.649649
MNT 3579.92745
MOP 8.078178
MRU 39.910387
MUR 47.239729
MVR 15.450132
MWK 1734.006734
MXN 17.475325
MYR 4.071034
MZN 63.898173
NAD 16.430635
NGN 1381.770115
NIO 36.800779
NOK 9.932698
NPR 151.185701
NZD 1.768765
OMR 0.384503
PAB 1.000018
PEN 3.414923
PGK 4.390353
PHP 61.180055
PKR 278.074382
PLN 3.758745
PYG 6089.674735
QAR 3.645212
RON 4.595597
RSD 102.898373
RUB 77.747658
RWF 1467.978395
SAR 3.756538
SBD 8.051953
SCR 14.898309
SDG 600.000346
SEK 9.71992
SGD 1.293475
SHP 0.746601
SLE 24.810284
SLL 20969.503664
SOS 571.521265
SRD 37.482969
STD 20697.981008
STN 21.482654
SVC 8.749978
SYP 110.532098
SZL 16.426633
THB 33.249768
TJS 9.269869
TMT 3.5
TND 2.962063
TOP 2.40776
TRY 46.642315
TTD 6.798104
TWD 31.892704
TZS 2627.582994
UAH 44.880508
UGX 3665.2038
UYU 40.238326
UZS 12052.207233
VES 620.752985
VND 26290
VUV 119.179282
WST 2.780883
XAF 575.16627
XAG 0.017168
XAU 0.000247
XCD 2.70255
XCG 1.802247
XDR 0.716371
XOF 575.168792
XPF 104.571381
YER 238.625005
ZAR 16.415401
ZMK 9001.200271
ZMW 18.104658
ZWL 321.999592
  • CMSC

    0.0700

    22

    +0.32%

  • RBGPF

    0.2000

    61.5

    +0.33%

  • RYCEF

    -0.0500

    18.7

    -0.27%

  • RIO

    0.0400

    93.78

    +0.04%

  • BCC

    -3.3400

    77.68

    -4.3%

  • AZN

    1.1200

    189.53

    +0.59%

  • BCE

    -0.2900

    22.63

    -1.28%

  • NGG

    0.3350

    83.345

    +0.4%

  • JRI

    0.1000

    12.89

    +0.78%

  • CMSD

    0.1000

    21.87

    +0.46%

  • VOD

    -0.2270

    13.663

    -1.66%

  • BTI

    -0.2800

    62.48

    -0.45%

  • GSK

    -0.0750

    52.425

    -0.14%

  • BP

    0.3950

    37.525

    +1.05%

  • RELX

    0.0250

    31.365

    +0.08%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: © AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

I.Taylor--ThChM--ThChM